Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Veracyte Inc shares valued at $76,920 were sold by McGuire Annie on Sep 19 ’25. At $33.69 per share, McGuire Annie sold 2,283 shares. The insider’s holdings dropped to 91,599 shares worth approximately $3.01 million following the completion of this transaction.
Also, ANN MCGUIRE purchased 2,283 shares, netting a total of over 75,864 in proceeds.
Before that, Stapley Marc had sold 7,667 shares from its account. In a trade valued at $233,133, the Chief Executive Officer traded Veracyte Inc shares for $30.41 each. Upon closing the transaction, the insider’s holdings decreased to 7,667 shares, worth approximately $10.97 million.
As published in their initiating research note from Craig Hallum on March 20, 2025, Veracyte Inc [VCYT] has been a Buy and the price target has been revised to $45. Analysts at Goldman downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early December. As of November 15, 2024, Wolfe Research has initiated its “an Outperform” rating for VCYT. Earlier on October 16, 2024, UBS initiated its rating. Their recommendation was “a Buy” for VCYT stock.
Analyzing VCYT Stock Performance
On last trading session, Veracyte Inc [NASDAQ: VCYT] rose 0.43% to $32.82. The stock’s lowest price that day was $31.81, but it reached a high of $33.14 in the same session. During the last five days, there has been a drop of approximately -1.23%. Over the course of the year, Veracyte Inc shares have dropped approximately -4.20%. Shares of the company reached a 52-week high of $47.32 on 01/30/25 and a 52-week low of $22.61 on 07/18/25.
Support And Resistance Levels for Veracyte Inc (VCYT)
According to the 24-hour chart, there is a support level at 32.04, which, if violated, would cause prices to drop to 31.26. In the upper region, resistance lies at 33.37. The next price resistance is at 33.92. RSI (Relative Strength Index) is 57.81 on the 14-day chart, showing neutral technical sentiment.
Is Veracyte Inc subject to short interest?
Stocks of Veracyte Inc saw a sharp steep in short interest on 2025-08-29 dropping by -1.03 million shares to 8.04 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 9.08 million shares. A decline of -12.86% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.71 of the overall float, the days-to-cover ratio (short ratio) decline to 5.71.
Which companies own the most shares of Veracyte Inc (VCYT)?
In terms of Veracyte Inc share price expectations, FactSet research, analysts set an average price target of 28 in the next 12 months, down nearly -14.32% from the previous closing price of $32.68. Analysts anticipate Veracyte Inc stock to reach 28 by 2025, with the lowest price target being 28. In spite of this, 0 analysts ranked Veracyte Inc stock as nan at the end of 2025. On October 10, 2024, Guggenheim assigned a price target of “a Buy” to the stock and initiated coverage with a $40.
